These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 32803850)

  • 21. COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia.
    Paulukonis ST; Snyder A; Smeltzer MP; Sutaria AN; Hurden I; Latta K; Chennuri S; Vichinsky E; Reeves SL
    J Pediatr Hematol Oncol; 2023 May; 45(4):174-180. PubMed ID: 37083273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
    Oluwole EO; Adeyemo TA; Osanyin GE; Odukoya OO; Kanki PJ; Afolabi BB
    PLoS One; 2020; 15(12):e0242861. PubMed ID: 33270733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests.
    Olaniyan HS; Briscoe C; Muhongo M; Pascoal R; Armando A; Santos B; McGann PT
    Blood Adv; 2023 Oct; 7(19):5860-5867. PubMed ID: 37399450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
    Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
    Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.
    Dexter D; McGann PT
    Pharmacotherapy; 2023 May; 43(5):430-441. PubMed ID: 36906823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.
    Kavanagh PL; Wang CJ; Therrell BL; Sprinz PG; Bauchner H
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):15-22. PubMed ID: 18200513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
    Dexter D; McGann PT
    Br J Haematol; 2022 Jan; 196(1):63-69. PubMed ID: 34340260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers and facilitators to community acceptability of integrating point-of-care testing to screen for sickle cell disease in children in primary healthcare settings in rural Upper East Region of Northern Ghana.
    Chatio ST; Duah E; Ababio LO; Lister N; Egbujo O; Marfo K; Aborigo R; Ansah P; Odame I
    PLoS One; 2024; 19(5):e0303520. PubMed ID: 38768171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sickle cell disease in the Zanzibar Archipelago, the Republic of Tanzania.
    Richert W; Atumani MO; Kołodziej D; Korzeniewski K
    Int Marit Health; 2024; 75(1):43-48. PubMed ID: 38647058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti.
    Alvarez OA; St Victor Dély N; Paul Hanna M; Saint Fleur R; Cetoute M; Metalonis S; Hustace T; Brown EC; Marcelin LH; Muscadin E; Eveillard R; Lerebours E
    Blood Adv; 2024 Jan; 8(1):14-22. PubMed ID: 37820110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Paper-Based Test for Screening Newborns for Sickle Cell Disease.
    Piety NZ; George A; Serrano S; Lanzi MR; Patel PR; Noli MP; Kahan S; Nirenberg D; Camanda JF; Airewele G; Shevkoplyas SS
    Sci Rep; 2017 Apr; 7():45488. PubMed ID: 28367971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal screening for sickle cell disease in France.
    Bardakdjian-Michau J; Bahuau M; Hurtrel D; Godart C; Riou J; Mathis M; Goossens M; Badens C; Ducrocq R; Elion J; Perini JM
    J Clin Pathol; 2009 Jan; 62(1):31-3. PubMed ID: 19103855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sickle cell disease and pregnancy outcomes: a study of the community-based hospital in a tribal block of Gujarat, India.
    Desai G; Anand A; Shah P; Shah S; Dave K; Bhatt H; Desai S; Modi D
    J Health Popul Nutr; 2017 Jan; 36(1):3. PubMed ID: 28109314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
    Smart LR; Ambrose EE; Raphael KC; Hokororo A; Kamugisha E; Tyburski EA; Lam WA; Ware RE; McGann PT
    Ann Hematol; 2018 Feb; 97(2):239-246. PubMed ID: 29147848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
    Nnodu O; Isa H; Nwegbu M; Ohiaeri C; Adegoke S; Chianumba R; Ugwu N; Brown B; Olaniyi J; Okocha E; Lawson J; Hassan AA; Diaku-Akinwumi I; Madu A; Ezenwosu O; Tanko Y; Kangiwa U; Girei A; Israel-Aina Y; Ladu A; Egbuzu P; Abjah U; Okolo A; Akbulut-Jeradi N; Fernandez M; Piel FB; Adekile A
    Blood Cells Mol Dis; 2019 Sep; 78():22-28. PubMed ID: 30773433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
    Kuznik A; Habib AG; Munube D; Lamorde M
    BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newborn screening for sickle cell disease in Kisangani, Democratic Republic of the Congo: an update.
    Kasai ET; Gulbis B; Ntukamunda JK; Bours V; Batina Agasa S; Marini Djang'eing'a R; Boemer F; Katenga Bosunga G; Ngbonda Dauly N; Sokoni Vutseme J; Boso Mokili B; Alworong'a Opara JP
    Hematology; 2023 Dec; 28(1):2213043. PubMed ID: 37183964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
    Guindo A; Cisse Z; Keita I; Desmonde S; Sarro YDS; Touré BA; Baraika MA; Tessougué O; Guindo P; Coulibaly M; Traore O; Sylla N; Diassana M; Saye A; Picot V; Lauressergues E; Leroy V
    Br J Haematol; 2024 Jan; 204(1):337-345. PubMed ID: 37728227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of preoperative screening for sickle cell disease in a population with a newborn screening program: a cohort study.
    O'Leary JD; Odame I; Pehora C; Chakraborty P; Crawford MW
    Can J Anaesth; 2013 Jan; 60(1):54-9. PubMed ID: 23104576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verbal autopsy as a tool for identifying children dying of sickle cell disease: a validation study conducted in Kilifi district, Kenya.
    Ndila C; Bauni E; Nyirongo V; Mochamah G; Makazi A; Kosgei P; Nyutu G; Macharia A; Kapesa S; Byass P; Williams TN
    BMC Med; 2014 Apr; 12():65. PubMed ID: 24755265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.